This reports a 40 year old man with cerebrotendinous xanthomatosis who had bilateral cataracts, enlarged Achilles tendons, progressive dementia, gait disturbance and peripheral neuropathy. Electroencephalography, electromyography, and magnetic resonance imaging (MRI) of the brain and spine were performed. Magnetic resonance imaging revealed cerebral, cerebellar and cervical cord atrophy and white matter involvement in the cerebrum and cerebellum correlating well with the clinical findings. To date there has been one previous report of MRI of the brain in cerebrotendinous xanthomatosis and none of the spinal cord.
graphy, and magnetic resonance imaging (MRI) of the brain and spine were performed. Magnetic resonance imaging revealed cerebral, cerebellar and cervical cord atrophy and white matter involvement in the cerebrum and cerebellum correlating well with the clinical findings. To date there has been one previous report of MRI of the brain in cerebrotendinous xanthomatosis and none of the spinal cord. Pathological studies7 disclosed cerebral and cerebellar atrophy and extensive secondary demyelination due to sterol accumulation in the cerebellum, posterior and lateral columns of the spinal cord. Lipid storage was found in the cytoplasm of perivascular mononuclear cells.
Cerebrotendinous xanthomatosis (CTX) is
The MRI findings of our patient support the clinical presentation. Diffuse cerebral atrophy accounts for the progressing dementia while white matter disease of the cerebellum correlates with ataxia and speech disturbance. The lower extremity weakness and diffusely brisk deep tendon reflexes may correlate with cervical cord involvement.
MRI is a more sensitive tool for detecting white matter disease in the central nervous system than computed tomography;89 however, it cannot differentiate among different disease processes such as leukodystrophies, Binswanger's disease or multiple sclerosis. The presence of both brain and spinal cord demyelination narrows down the differential diagnosis to diseases that affect both, for example, multiple sclerosis and cerebrotendinous xanthomatosis.
MRI may become valuable in establishing the diagnosis of CTX early and monitoring treatment efficacy. With better understanding of the underlying biochemical abnormalities in CTX, treatment became possible and it encourages clinicians to establish the diagnosis early in the course of this disease. Hepatic bile synthesis is defective in CTX and it results in reduced cholic acid and chenodenoxycholic acid synthesis and continuous deposition of cholestanol as well as replacement of cholesterol with cholestanol in the central and peripheral nervous system. Chenodeoxycholic acid treatment has stabilised the disease and often improved neurological function.34 
